New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
16:10 EDTRCPTReceptos files to sell common stock, no amount given
Receptos intends to use the net proceeds received from this offering to fund continued development of its product candidate RPC1063 in ongoing clinical trials for relapsing multiple sclerosis and ulcerative colitis, development of its in-licensed product candidate RPC4046 in a clinical trial for eosinophilic esophagitis, other ongoing preclinical and research programs and for general corporate purposes including working capital. International, Inc. are acting as co-managers. Credit Suisse Securities, Leerink Partners LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering. Wedbush PacGrow Life Sciences and Nomura Securities
News For RCPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
10:00 EDTRCPTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:55 EDTRCPTReceptos initiated with a Buy at UBS
Subscribe for More Information
April 16, 2015
09:30 EDTRCPTReceptos announcement a positive surprise, says Leerink
Subscribe for More Information
08:08 EDTRCPTReceptos reports positive results for maintenance period of ozanimod trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use